Blue water vaccines announces signing of sponsored research agreement with cincinnati children's hospital medical center for s&p vaccine platform development

Cincinnati, july 20, 2022 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or “the company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that the company has entered into a sponsored research agreement (the “sra”) with cincinnati children's hospital medical center (“cincinnati children's”) to explore vaccine development of its norovirus shell and protrusion (s&p) platform for multiple diseases.
BWV Ratings Summary
BWV Quant Ranking